Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study

被引:94
|
作者
Galderisi, Silvana [1 ]
Davidson, Michael [2 ]
Kahn, Rene S. [3 ]
Mucci, Armida [1 ]
Boter, Han [3 ]
Gheorghe, Mihai D. [4 ]
Rybakowski, Janusz K. [5 ]
Libiger, Jan [6 ,7 ]
Dollfus, Sonia [8 ]
Lopez-Ibor, Juan J. [9 ]
Peuskens, Joseph [10 ]
Hranov, Luchezar G. [11 ]
Fleischhacker, Wolfgang W. [12 ]
机构
[1] Univ Naples Federico II, Dept Psychiat, SUN, I-80138 Naples, Italy
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[3] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
[4] Cent Mil Hosp, Dept Psychiat, Bucharest, Romania
[5] Univ Med Sci, Dept Adult Psychiat, Poznan, Poland
[6] Charles Univ Prague, Dept & Clin Psychiat, Sch Med, Hradec Kralove, Czech Republic
[7] Fac Hosp, Hradec Kralove, Czech Republic
[8] CHU Caen, Ctr Esquirol, F-14000 Caen, France
[9] Hosp Clin San Carlos, Inst Psychiat & Mental Hlth, Madrid, Spain
[10] Katholieke Univ Leuven, Univ Psychiat Ctr, Louvain, Belgium
[11] Univ Hosp Neurol & Psychiat St Naum, Dept & Clin Psychiat, Sofia, Bulgaria
[12] Med Univ Innsbruck, Dept Biol Psychiat, Innsbruck, Austria
关键词
Cognition; Neuropsychology; Psychopathological dimensions; Antipsychotics; Duration of untreated psychosis; Psychosis; 1ST-EPISODE SCHIZOPHRENIA; UNTREATED PSYCHOSIS; ANTIPSYCHOTIC-DRUGS; SUBSTANCE-ABUSE; DURATION; SYMPTOMS; DEFICITS; ONSET; LATERALITY; DISORDER;
D O I
10.1016/j.schres.2009.09.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Profile and correlates of cognitive deficits in first episode (FE) schizophrenia patients are still debated. The present study is aimed to clarify in a large sample of FIE patients the extent of impairment in key cognitive domains and its relationships with demographic and clinical variables. Method: The European First Episode Schizophrenia Trial collected demographic, clinical and neurocognitive baseline data in 498 FE patients with minimal or no prior exposure to antipsychotics. Two-hundred-twenty healthy subjects (HS) were also evaluated. Neurocognitive assessment included the Rey Auditory Verbal Learning Test: Trail Making A and B, Purdue Pegboard and Digit-Symbol Coding. Results: Patients performed worse than HS on all tests (effect sizes from - 0.88 to - 1,73). Correlations with psychopathological dimensions were weak and involved reality distortion and disorganization. The duration of untreated psychosis (DUP) was not associated with cognitive impairment. Subjects living alone had a better neurocognitive performance, while the occupation status did not reveal any association with cognition. Conclusions: A moderate/severe impairment of processing speed, motor dexterity, verbal memory and cognitive flexibility was found in the largest sample of FE patients analyzed so far. The impairment was largely independent from psychopathology and not associated with DUP. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:104 / 114
页数:11
相关论文
共 50 条
  • [11] The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
    Fleischhacker, WW
    Keet, IPM
    Kahn, RS
    SCHIZOPHRENIA RESEARCH, 2005, 78 (2-3) : 147 - 156
  • [12] Predictors of adherence to antipsychotic treatment in first episode schizophrenia results of the Romanian cohort in the EUFEST study
    Matei, V.
    Mihailescu, A. I.
    Al-Bataineh, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S513 - S514
  • [13] Extrapyramidal symptoms during treatment of first schizophrenia episode: Results from EUFEST
    Rybakowski, Janusz K.
    Vansteelandt, Kristof
    Remlinger-Molenda, Agnieszka
    Fleischhacker, W. Wolfgang
    Kahn, Rene S.
    Peuskens, Joseph
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (09) : 1500 - 1505
  • [14] Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study
    Wobrock, T.
    Falkai, P.
    Schneider-Axmann, T.
    Hasan, A.
    Galderisi, S.
    Davidson, M.
    Kahn, R. S.
    Derks, E. M.
    Boter, H.
    Rybakowski, J. K.
    Libiger, J.
    Dollfus, S.
    Lopez-Ibor, J. J.
    Peuskens, J.
    Hranov, L. G.
    Gaebel, W.
    Fleischhacker, W. W.
    SCHIZOPHRENIA RESEARCH, 2013, 147 (01) : 132 - 139
  • [15] Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
    Matei, Valentin Petre
    Mihailescu, Alexandra Ioana
    Gheorghe, Iuliana Raluca
    Grigoras, Ruxandra
    Crasan, Andrei
    Rosca, Alina
    Popa-Velea, Ovidiu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 1279 - 1284
  • [16] Cognitive correlates of semantic language disorder in first-episode schizophrenia
    Chen, E. Y.
    Hui, C. L.
    Chiu, C. P.
    Law, C. W.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 214 - 214
  • [17] Cognitive impairment predicted by the degree of premorbid deterioration in first episode schizophrenia
    Fannon, D
    Riley, E
    Doku, V
    O'Ceallaigh, S
    Tennakoon, L
    Chitnis, X
    McGovern, D
    Sharma, T
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 45 - 45
  • [18] Cognitive impairment predicted by the degree of premorbid deterioration in first episode schizophrenia
    Fannon, D
    Riley, E
    Doku, V
    O'Ceallaigh, S
    Tennakoon, L
    Chitnis, X
    Sumich, A
    Sharma, T
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 51S - 51S
  • [19] Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis
    Garcia Alvarez, Leticia
    Gomar, Jesus J.
    Paz Garcia-Portilla, Ma
    Bobes, Julio
    ADICCIONES, 2019, 31 (02) : 89 - 94
  • [20] Cognitive impairment and cortisol levels in first-episode schizophrenia patients
    Havelka, David
    Prikrylova-Kucerova, Hana
    Prikryl, Radovan
    Ceskova, Eva
    STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2016, 19 (04): : 383 - 389